Clinical Trial Update: Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease [NA]

View source ↗

Summary

The clinical trial evaluating iron prophylaxis to prevent anemia in infants with cyanotic congenital heart disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cyanotic Congenital Heart Disease

Drugs mentioned

• Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Emory University | Conditions: Anemia | NA | Status: WITHDRAWN